German Food Stock News

XTRA:CBK
XTRA:CBKBanks

Is It Too Late To Consider Commerzbank (XTRA:CBK) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether Commerzbank stock still offers value after a strong run, this article breaks down what the current price might be implying. The share price recently closed at €35.41, with returns of 0.6% over 7 days, 3.1% over 30 days, a 2.7% decline year to date and 43.3% over the last year, along with very large gains over 3 and 5 years. Recent headlines have focused on Commerzbank as a key player among German banks, with investors watching how it positions itself within the...
XTRA:HAG
XTRA:HAGAerospace & Defense

How Investors May Respond To Hensoldt (XTRA:HAG) Record Order Backlog And Narrowing Quarterly Loss

Hensoldt AG recently reported its first-quarter 2026 results, with sales rising to €496 million from €395 million a year earlier and its net loss narrowing to €19 million from €30 million. The company also highlighted a record €9.80 billion order book, underpinned by major defense contracts, while stating that recent Chinese dual-use export restrictions are not expected to have a material financial impact. We’ll now examine how Hensoldt’s record €9.80 billion order book may influence the...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Is Bayer (XTRA:BAYN) Offering Opportunity After 54.3% One Year Share Price Gain?

If you are wondering whether Bayer's share price is offering value right now, it helps to first line up what the current valuation signals are really saying. The stock closed at €36.99, with returns of 54.3% over 1 year but declines of 2.8% over 7 days, 8.6% over 30 days, and 2.7% year to date. These figures can influence how the market is weighing both opportunity and risk. Recent coverage has focused on Bayer's ongoing restructuring efforts and legal overhangs, issues that many investors...
XTRA:DHL
XTRA:DHLLogistics

Deutsche Post DHL (XTRA:DHL) Net Margin Progress Tests Bearish Long Term Earnings Narrative

Deutsche Post (XTRA:DHL) opened 2026 with Q1 revenue of about €20.4b and basic EPS of €0.73, alongside trailing twelve month revenue of roughly €83.0b and EPS of €3.14 that sit against a backdrop of 4.4% earnings growth over the past year. Over recent quarters, the company has seen revenue move from €23.3b and EPS of €0.95 in Q4 2024 to €21.1b and EPS of €0.68 in Q1 2025, before reaching €22.7b and €0.95 in Q4 2025 and then €20.4b and €0.73 in the latest quarter. A trailing net margin holding...
XTRA:PUM
XTRA:PUMLuxury

PUMA CFO Shift What Mark Langer’s Appointment Could Mean For Investors

PUMA SE (XTRA:PUM) has appointed Mark Langer as Chief Financial Officer and Member of the Management Board. The appointment is effective from May 1, 2026. The change represents a key leadership shift in PUMA's senior management team. PUMA SE operates as a global sportswear and athletic footwear company, competing with other major consumer brands for market share and customer attention. The sector is influenced by shifting consumer preferences, brand partnerships and broader trends in...
XTRA:BAS
XTRA:BASChemicals

Are BASF’s (XTRA:BAS) Rising EPS And Flat Sales Recasting Its Earnings Quality Story?

In the first quarter of 2026, BASF SE reported sales of €16,020 million, slightly below the prior year, while net income rose to €927 million and basic earnings per share increased to €1.06 from €0.91. This profit improvement, combined with a projected expansion of the global ammonium sulfate market where BASF is a key player, highlights how product mix and sector trends may be supporting higher earnings quality despite flat revenues. With BASF’s higher quarterly earnings and stronger...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Margin Stability At 9.1% Tests Bullish Expansion Narrative

Siemens Healthineers (XTRA:SHL) opened Q1 2026 with revenue of €5.4b and basic EPS of €0.40, alongside net income of €449m for the quarter, setting a clear benchmark for how the rest of the year might unfold. Over the past year, quarterly revenue has moved between €5.4b and €6.3b while basic EPS ranged from €0.40 to €0.55. Trailing twelve month EPS stands at about €1.89 on revenue of roughly €23.3b, providing a clearer view of the earnings profile behind the latest results. With a trailing...
XTRA:VNA
XTRA:VNAReal Estate

Assessing Vonovia (XTRA:VNA) Valuation After Mixed Signals In Its Latest Quarterly Earnings

Q1 earnings and shifting signals for Vonovia Vonovia (XTRA:VNA) has moved into focus after its first quarter 2026 earnings, where modest sales of €1,218.8 million contrasted with a sharp year-on-year drop in net income to €210.5 million. At the same time, management highlighted growth in Rental adjusted EBITDA, stronger Value-add EBITDA and progress on reducing leverage. This gives investors a mix of weaker headline profit and more resilient underlying operations to weigh. See our latest...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Expands AI Sensors And Enters Connected Senior Care Market

Infineon Technologies (XTRA:IFX) is acquiring the non-optical sensor business from ams OSRAM, expanding its sensor portfolio for AI and data center uses. The company is also partnering with the Health Impact Alliance to develop connectivity solutions for senior care within a new healthcare ecosystem. These developments have not been covered in recent Simply Wall St articles and may influence how investors view Infineon's future positioning. Infineon Technologies enters these deals with...
XTRA:EVK
XTRA:EVKChemicals

Evonik Industries (XTRA:EVK) Margin Improvement Tests Bullish Profitability Narrative

Evonik Industries (XTRA:EVK) closed FY 2025 with fourth quarter revenue of €3.4b and basic EPS of €0.04, while for the trailing twelve months revenue was €14.1b and basic EPS was €0.57, alongside net income of €265m. Over recent quarters, revenue has ranged from €3.4b to €3.8b and quarterly basic EPS has moved between a loss of €0.23 and a profit of €0.50, giving investors a clear view of how the earnings profile has shifted through the year. With net profit margins at 1.9% over the last...
XTRA:SMHN
XTRA:SMHNSemiconductor

SUSS MicroTec (XTRA:SMHN) Margin Compression Challenges Bullish Expansion Narrative

SUSS MicroTec (XTRA:SMHN) has just posted its FY 2025 numbers, with Q4 revenue of €118.8 million and basic EPS of €0.51, while the trailing twelve months show revenue of €503.2 million and EPS of €2.59. Over recent periods the company has seen quarterly revenue move between €102.5 million and €151.4 million and quarterly EPS range from €0.48 to €0.85, giving investors a clear view of how top line and EPS have tracked together across the last six quarters. With the latest figures in hand, the...
XTRA:SRT3
XTRA:SRT3Life Sciences

Is It Time To Reconsider Sartorius (XTRA:SRT3) After Its Recent Share Price Slide?

This article examines whether Sartorius is attractively priced or still demanding at today’s levels by walking through what the current share price might be implying about value. The stock last closed at €221.50, with returns of 2.0% over 7 days and 6.4% over 30 days, while year to date performance stands at a 10.6% decline and the 1 year return is a 2.5% decline. Over the past 3 and 5 years, shareholders have experienced declines of 35.7% and 45.2%. This provides important context for...
XTRA:DBK
XTRA:DBKCapital Markets

Is Deutsche Bank (XTRA:DBK) Still Attractively Priced After Mixed Recent Share Performance?

If you are wondering whether Deutsche Bank at €27.20 is still reasonably priced or already stretched, the key is to look closely at what the current valuation is really implying. The stock has moved 2.6% over the last week and 6.1% over the last month, while year to date it is down 19.0% and up 17.9% over the last year. Recent returns therefore give a mixed picture of risk and opportunity. Recent coverage has focused on how investors are reassessing large European banks and their capital...
XTRA:FME
XTRA:FMEHealthcare

A Look At Fresenius Medical Care (XTRA:FME) Valuation After Mixed Q1 2026 Results And €1b Share Buyback

Fresenius Medical Care (XTRA:FME) is back in focus after first quarter 2026 earnings showed mixed results, alongside confirmation of flat full year guidance and completion of a €1b share buyback representing about 8.5% of share capital. See our latest analysis for Fresenius Medical Care. Despite the 3.82% 1 day share price return taking the stock to €37.2, Fresenius Medical Care’s 30 day share price return of 4.88% and 1 year total shareholder return of 23.41% point to fading momentum...
XTRA:ZAL
XTRA:ZALSpecialty Retail

Is Zalando (XTRA:ZAL) Now Attractive After A 35% One-Year Share Price Slide?

Wondering whether Zalando at €20.28 is starting to look like value or still has more risk priced in? This article breaks down what the current share price implies. The stock has faced sustained pressure, with returns of a 3.6% decline over the last week, 1.1% decline over the last month, 17.8% decline year to date and 35.5% decline over the past year. This context helps explain how the market is currently thinking about its prospects. Recent coverage has focused on how Zalando is adjusting...
XTRA:BMW
XTRA:BMWAuto

BMW E Ink iX3 Flow Edition Puts Spotlight On Valuation Gap

BMW, listed as XTRA:BMW, unveiled the iX3 Flow Edition with E Ink Prism at the Beijing Auto Show 2026. The model is described as the first series ready integration of E Ink exterior technology on a production automobile. The E Ink based exterior allows customizable, digital patterns on the vehicle body rather than remaining a concept stage feature. At a share price of €81.4, XTRA:BMW sits against a mixed recent track record, with the stock up 5.0% over the past week and 12.9% over the past...
XTRA:MBG
XTRA:MBGAuto

Weaker Q1 Earnings and US Tariff Risks Might Change The Case For Investing In Mercedes-Benz Group (XTRA:MBG)

In the first quarter of 2026, Mercedes-Benz Group AG reported sales of €25,497 million and net income of €1,418 million, both lower than a year earlier. At the same time, renewed US tariff threats on European cars have added policy uncertainty to Mercedes-Benz’s already pressured automotive earnings profile. Next, we’ll explore how weaker quarterly profitability amid renewed US tariff risks could influence Mercedes-Benz Group’s existing investment narrative. The latest GPUs need a type of...